NLSP logo

NLS Pharmaceutics AG (NLSP) EBITDA

Annual EBITDA

-$12.02 M
+$4.37 M+26.66%

December 1, 2023


Summary


Performance

NLSP EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNLSPprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

NLSP EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+26.7%--
3 y3 years-357.3%--
5 y5 years-195.8%--

NLSP EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1.2%+26.7%
5 y5-year-357.3%+26.7%
alltimeall time-357.3%+26.7%

NLS Pharmaceutics AG EBITDA History

DateAnnualQuarterlyTTM
Dec 2023
-$12.02 M(-26.7%)
-
-
Dec 2022
-$16.38 M(+38.0%)
-
-
Dec 2021
-$11.87 M(+351.6%)
-
-
DateAnnualQuarterlyTTM
Dec 2020
-$2.63 M(-43.2%)
-
-
Dec 2019
-$4.63 M(+13.9%)
-
-
Dec 2018
-$4.06 M(-29.6%)
-
-
Dec 2017
-$5.77 M
-
-

FAQ

  • What is NLS Pharmaceutics AG annual EBITDA?
  • What is the all time high annual EBITDA for NLS Pharmaceutics AG?
  • What is NLS Pharmaceutics AG annual EBITDA year-on-year change?

What is NLS Pharmaceutics AG annual EBITDA?

The current annual EBITDA of NLSP is -$12.02 M

What is the all time high annual EBITDA for NLS Pharmaceutics AG?

NLS Pharmaceutics AG all-time high annual EBITDA is -$2.63 M

What is NLS Pharmaceutics AG annual EBITDA year-on-year change?

Over the past year, NLSP annual EBITDA has changed by +$4.37 M (+26.66%)